{"id":1266,"date":"2014-12-19T11:31:18","date_gmt":"2014-12-19T16:31:18","guid":{"rendered":"http:\/\/blogs.cooperhealth.org\/sjmedicalreport\/?p=1266"},"modified":"2022-04-25T15:34:32","modified_gmt":"2022-04-25T15:34:32","slug":"cooper-offers-advanced-ablation-therapy-for-barretts-esophagus","status":"publish","type":"post","link":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/2014\/12\/19\/cooper-offers-advanced-ablation-therapy-for-barretts-esophagus\/","title":{"rendered":"Cooper  Offers Advanced Ablation Therapy for Barrett\u2019s Esophagus"},"content":{"rendered":"<p>Of the estimated 20 percent of Americans who are chronic GERD sufferers, 10 percent to 15 percent will develop Barrett\u2019s esophagus. This premalignant condition increases the risk of developing esophageal adenocarcinoma, one of the fastest-growing cancers in the U.S. today\u2013 and one of the most lethal, with a dismal 15 percent five-year survival rate. In fact, individuals with Barrett\u2019s have a 30 &#8211; to 40 -times higher incidence of developing <a href=\"http:\/\/www.cooperhealth.org\/services\/esophageal-cancer\">esophageal cancer<\/a> than those without the condition.<\/p>\n<p>Cooper University Hospital offers the state-of-the-art HALO\u00ae System, an advanced radio-frequency ablation (RFA) technology for treating Barrett\u2019s esophagus that removes the Barrett\u2019s epithelium in a short, well-tolerated endoscopic procedure. Cooper offers this non- surgical treatment that has over a 90 percent success rate in eradicating Barrett\u2019s esophagus. \u201cAnyone with a history of Barrett\u2019s should discuss the potential value of RFA treatment with his\/her primary care physician or gastroenterologist, particularly those with long- segment Barrett\u2019s \u2013 greater than 3 cm \u2013 and those who\u2019ve had the condition for years,\u201d advises Cooper gastroenterologist <a href=\"http:\/\/www.cooperhealth.org\/physicians\/joshua-p-desipio-md\">Joshua P. DeSipio,\u00a0MD<\/a> . Prior to the availability of RFA, the standard treatment for Barrett\u2019s esophagus was surveillance to monitor the progression of the disease.<\/p>\n<p>\u201cThis procedure may be an alternative to watchful waiting for patients who have precancerous findings, such as low- or high-grade dysplasia, whose disease has not yet advanced to the point where surgery is needed,\u201d Dr. DeSipio notes. It may also be considered in select individuals with non-dysplastic Barrett\u2019s who are at increased risk of progression.<\/p>\n<p>\u201cRadio-frequency ablation provides uniform and controlled ablative therapy that not only removes the abnormal cells but also allows for regrowth of normal cells,\u201d Dr. DeSipio says. Performed in an outpatient setting, it generally takes less than\u00a030 minutes. Most patients require two to three treatments.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Of the estimated 20 percent of Americans who are chronic GERD sufferers, 10 percent to 15 percent will develop Barrett\u2019s esophagus. This premalignant condition increases the risk of developing esophageal adenocarcinoma, one of the fastest-growing cancers in the U.S. today\u2013 and one of the most lethal, with a dismal 15 percent five-year survival rate. In fact, individuals with Barrett\u2019s have a 30 &#8211; to 40 -times higher incidence of developing esophageal cancer than those without the condition.<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3,4],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-dzarnosky","4":"has-excerpt","5":"post-1266","7":"format-standard","8":"category-featured","9":"category-news-updates"},"_links":{"self":[{"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/posts\/1266","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/comments?post=1266"}],"version-history":[{"count":6,"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/posts\/1266\/revisions"}],"predecessor-version":[{"id":1942,"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/posts\/1266\/revisions\/1942"}],"wp:attachment":[{"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/media?parent=1266"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/categories?post=1266"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/tags?post=1266"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}